Trials / Completed
CompletedNCT03438929
Evaluation of Diolaze XL Blended Mode for Hair Removal
Clinical Evaluation of Diolaze XL Blended Mode for Hair Removal
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 31 (actual)
- Sponsor
- InMode MD Ltd. · Industry
- Sex
- Female
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Accepted
Summary
The objective of this clinical study is to evaluate safety and efficiency of Diolase XL blended modes for hair removal. The handpieces tested were a blend of 755nm/810nm and 810nm/1064nm. At least 30 female subjects seeking hair removal treatment will be enrolled. Treatment sites will be o groins and axillae. Study design included 3 treatment sessions 4 weeks apart and follow-up after 3 months.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Diode laser | Diolaze XL blended modes diode laser |
Timeline
- Start date
- 2017-08-14
- Primary completion
- 2018-01-30
- Completion
- 2018-02-10
- First posted
- 2018-02-20
- Last updated
- 2018-05-22
Locations
1 site across 1 country: Israel
Source: ClinicalTrials.gov record NCT03438929. Inclusion in this directory is not an endorsement.